PBH 250117 85.00P (PBH250117P85000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

PBH250117P85000

Watchlist

0.00
0.000.00%

15min DelayClose Dec 30 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Earnings Call Summary | Prestige Consumer Healthcare(PBH.US) Q2 2025 Earnings Conference
moomoo AIDec 30 06:04 ET · Conference Call
Should Prestige Consumer Stock Stay in Your Portfolio Right Now?
Zacks Dec 26 06:30 ET
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 49% Below Their Intrinsic Value Estimate
Simply Wall StDec 25 09:19 ET
Sidoti Initiates Prestige Consumer Healthcare(PBH.US) With Hold Rating, Announces Target Price $90
Moomoo NewsDec 9 09:31 ET · Ratings
Has Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Yahoo FinanceDec 9 06:39 ET
Prestige Consumer Healthcare (NYSE:PBH) Has A Pretty Healthy Balance Sheet
Simply Wall StDec 4 06:53 ET

Comments

Moomoo AI

Mar 26 09:08

Investors seem to focus more on the company's revenue growth despite the decrease in earnings per share. The company's long-term track record of an annual TSR of 20% over five years makes it a business worth watching.

Those Who Invested in Prestige Consumer Healthcare (NYSE:PBH) Five Years Ago Are up 144%

Moomoo AI

Mar 5 07:39

Investors may be expecting a turnaround in the company's lackluster revenue performance, hence the moderate P/S ratio. However, the company's muted revenue growth estimates compared to the industry make its current P/S ratio unexpected. A positive change is needed to justify this ratio.

Some Shareholders Feeling Restless Over Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S Ratio

Moomoo AI

Feb 11 07:43

Prestige Consumer Healthcare's revenue growth is predicted to slow, with an estimated annual growth rate of 1.9% until 2025, significantly below the historical 4.2% p.a. growth. Compared to industry peers forecasted to grow at 9.0% per year, Prestige is expected to lag behind.

Here's What Analysts Are Forecasting For Prestige Consumer Healthcare Inc. (NYSE:PBH) After Its Third-Quarter Results

Moomoo AI

Jan 30 12:35

An insider selling shares below the current price may suggest they deemed the lower price fair, questioning their view of the recent higher valuation. However, this is a weak sign as it doesn't imply insiders think the shares are fully valued. The level of insider ownership indicates a reasonable alignment with shareholder interests.

This Prestige Consumer Healthcare Insider Reduced Their Stake By 57%

Moomoo Breakfast US

May 10, 2022 07:18

Columns Today's pre-market stock movers: PTON, NVAX, AMC, SONY and more

Gainers:
• $Biohaven (BHVN.US)$ +70.3% (Biohaven Pharmaceutical and Pfizer (PFE) announce that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven)
• $Vroom (VRM.US)$ +33.3% (also CEO Paul Hennessy steps down; Tom Shortt appointed as CEO)
• $Nuvve (NVVE.US)$ +10.2% (NVVE and CENN announce alliance to offer electrification solution for commercial fleets)
• $ShockWave Medical (SWAV.US)$ +14.6% (I...